MAIA Biotechnology, Inc. (MAIA)
AMEX$1.67
Market Cap
$40.54M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
128 of 924
Rank in Industry
85 of 527
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
MAIA Insider Trading Activity
MAIA Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $1,342,954 | 12 | 100 |
Sells | $0 | 0 | 0 |
Related Transactions
| Smith Stan | director | 5 | $709,709 | 0 | $0 | $709,709 |
| Guerrero Ramiro | director | 4 | $482,218 | 0 | $0 | $482,218 |
| CHAOUKI STEVEN M | director | 1 | $55,554 | 0 | $0 | $55,554 |
| Luput Cristian | director | 1 | $55,554 | 0 | $0 | $55,554 |
| Louie Ngar Yee | director | 1 | $39,920 | 0 | $0 | $39,920 |
About MAIA Biotechnology, Inc.
MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded in 2018 and is headquartered in Chicago, Illinois.
Insider Activity of MAIA Biotechnology, Inc.
Over the last 12 months, insiders at MAIA Biotechnology, Inc. have bought $1.34M and sold $0 worth of MAIA Biotechnology, Inc. stock.
On average, over the past 5 years, insiders at MAIA Biotechnology, Inc. have bought $1.87M and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Smith Stan (director) — $709,709. Guerrero Ramiro (director) — $482,218. CHAOUKI STEVEN M (director) — $55,554.
The last purchase of 25,000 shares for transaction amount of $37,500 was made by Smith Stan (director) on 2025‑03‑03.
List of Insider Buy and Sell Transactions, MAIA Biotechnology, Inc.
| 2025-03-03 | Smith Stan | director | 25,000 0.0841% | $1.50 | $37,500 | -4.12% | ||
| 2025-03-03 | Guerrero Ramiro | director | 33,333 0.1121% | $1.50 | $50,000 | -4.12% | ||
| 2025-02-24 | Smith Stan | director | 50,000 0.16% | $1.50 | $75,000 | -7.46% | ||
| 2025-02-24 | Guerrero Ramiro | director | 73,333 0.2347% | $1.50 | $110,000 | -7.46% | ||
| 2024-12-13 | Smith Stan | director | 25,000 0.0933% | $1.87 | $46,800 | -5.25% | ||
| 2024-12-13 | Guerrero Ramiro | director | 53,418 0.1994% | $1.87 | $99,999 | -5.25% | ||
| 2024-11-01 | Smith Stan | director | 100,000 0.3818% | $2.51 | $251,000 | -27.27% | ||
| 2024-11-01 | Guerrero Ramiro | director | 88,534 0.338% | $2.51 | $222,220 | -27.27% | ||
| 2024-11-01 | Luput Cristian | director | 22,133 0.0845% | $2.51 | $55,554 | -27.27% | ||
| 2024-11-01 | CHAOUKI STEVEN M | director | 22,133 0.0845% | $2.51 | $55,554 | -27.27% | ||
| 2024-04-25 | Louie Ngar Yee | director | 19,665 0.1191% | $2.03 | $39,920 | +0.75% | ||
| 2024-04-25 | Smith Stan | director | 147,492 0.8932% | $2.03 | $299,409 | +0.75% | ||
| 2024-03-14 | Louie Ngar Yee | director | 170,940 1.0953% | $1.17 | $200,000 | +101.14% | ||
| 2024-03-14 | Smith Stan | director | 170,940 1.0953% | $1.17 | $200,000 | +101.14% | ||
| 2024-03-14 | Luput Cristian | director | 69,282 0.4439% | $1.17 | $81,060 | +101.14% | ||
| 2024-03-14 | Guerrero Ramiro | director | 6,928 0.0444% | $1.17 | $8,106 | +101.14% | ||
| 2024-03-14 | CHAOUKI STEVEN M | director | 34,641 0.222% | $1.17 | $40,530 | +101.14% | ||
| 2023-05-18 | Guerrero Ramiro | director | 1,200 0.0109% | $2.47 | $2,964 | -19.84% | ||
| 2023-05-15 | Luput Cristian | director | 3,000 0.0266% | $2.63 | $7,890 | -26.48% | ||
| 2023-04-28 | Vitoc Vlad | Chief Executive Officer | 4,000 0.037% | $2.50 | $10,000 | -19.92% |
Total: 113
*Gray background shows transactions not older than one year
Insider Historical Profitability
<0.0001%
| Smith Stan | director | 1205060 4.9636% | $2.01M | 43 | 0 | <0.0001% |
| Louie Ngar Yee | director | 1167189 4.8076% | $1.95M | 4 | 0 | +9.58% |
| Guerrero Ramiro | director | 568218 2.3404% | $948,924.06 | 19 | 0 | <0.0001% |
| Luput Cristian | director | 389483 1.6043% | $650,436.61 | 18 | 0 | <0.0001% |
| CHAOUKI STEVEN M | director | 111024 0.4573% | $185,410.08 | 3 | 0 | +22.94% |
*Gray background shows insiders who have made transactions during last year
Historical Insider Profitability vs. Competitors
MAIA Biotechnology, Inc. (MAIA) | $4,273,853 | 101 | -36.67% | $40.54M |
$1,695,621 | 55 | 17.90% | $42.86M | |
$15,956,086 | 53 | 5.33% | $47.48M | |
$140,938,207 | 36 | 14.75% | $40.58M | |
$23,895,365 | 34 | -37.28% | $37.13M |
MAIA Institutional Investors: Active Positions
| Increased Positions | 12 | +70.59% | 102,051 | +6.96% |
| Decreased Positions | 6 | -35.29% | 185,842 | -12.67% |
| New Positions | 6 | New | 55,222 | New |
| Sold Out Positions | 4 | Sold Out | 49,944 | Sold Out |
| Total Postitions | 23 | +35.29% | 1M | -5.71% |
MAIA Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Vanguard Group Inc | $903.00 | 2.24% | 582,507 | +16,133 | +2.85% | 2024-12-31 |
| Halter Ferguson Financial Inc. | $373.00 | 0.93% | 240,818 | -135,896 | -36.07% | 2024-12-31 |
| Geode Capital Management, Llc | $306.00 | 0.76% | 197,524 | +4,961 | +2.58% | 2024-12-31 |
| Blackrock, Inc. | $131.00 | 0.33% | 84,785 | +5,058 | +6.34% | 2024-12-31 |
| Centric Wealth Management | $106.00 | 0.26% | 68,219 | 0 | 0% | 2024-12-31 |
| State Street Corp | $83.00 | 0.21% | 53,250 | +18,850 | +54.8% | 2024-12-31 |
| Bridgeway Capital Management, Llc | $71.00 | 0.18% | 45,700 | 0 | 0% | 2024-12-31 |
| Jane Street Group, Llc | $61.00 | 0.15% | 39,057 | +39,057 | New | 2024-12-31 |
| Northern Trust Corp | $50.00 | 0.12% | 32,071 | 0 | 0% | 2024-12-31 |
| Wealth Enhancement Advisory Services, Llc | $23.00 | 0.06% | 14,800 | 0 | 0% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
No data is available at this moment.
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.